‹ All Posts
Saurabh Tyagi--Clovek,Advisory

23rd May 2025 · SEBI-Registered Analyst

SUNPHARMA
to ramp up specialty products portfolio in FY26 to drive growth

SUNPHARMA
projects revenue growth of mid- to high single digits in FY26 compared with an 8.5% increase in FY25

#FundamentalViews#WatchOutFor#StockInNews#MacroViews#EquityResearch
200 likes·44 comments